FDA Says No to MDMA as Therapy for PTSD
MONDAY, Aug. 12, 2024 (HealthDay News) — Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for post-traumatic stress disorder (PTSD). There is insufficient evidenceContinue Reading